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Expanding the scope of bioorthogonal reactivity requires access to new and mutually compatible reagents.
We report here that 1,2,4-triazines can be tuned to exhibit unique reaction proﬁles with biocompatible
strained alkenes and alkynes. Computational analyses were used to identify candidate orthogonal
reactions, and the predictions were experimentally veriﬁed. Notably, 5-substituted triazines, unlike their
6-substituted counterparts, undergo rapid [4 + 2] cycloadditions with a sterically encumbered strained
alkyne. This unique, sterically controlled reactivity was exploited for dual bioorthogonal labeling. Mutually
orthogonal triazines and cycloaddition chemistries will enable newmulti-component imaging applications.Bioorthogonal chemistries have been used extensively to tag
biomolecules in complex environments.1 The success of these
transformations is critically dependent on the stabilities of the
reagents in cells and tissues. At the same time, the reagents
must be robustly and singularly reactive with complementary
probes.2 This chemical paradox has oen frustrated eﬀorts to
develop reagents that exhibit selective reactivity, let alone
multiple reactions that function in concert. In fact, there are
only a handful of bioorthogonal reaction pairs that can be used
simultaneously.3–16
We are developing “privileged” scaﬀolds that not only meet
the requirements for bioorthogonality, but are also compat-
ible with existing reagents to enable tandem application.4,17
Such mutually orthogonal reagents are in demand for chem-
ical tagging of multiple biomolecules.5–14 We recently re-
ported that a 6-substituted 1,2,4-triazine constitutes a new
privileged scaﬀold (Fig. 1A).18 This motif reacts with trans-
cyclooctene (TCO) via inverse electron-demand Diels–Alder
(IED-DA) cycloaddition. The rate of this cycloaddition can belifornia, Irvine, California, 92697, USA.
y, University of California, Los Angeles,
istry, Jiangsu Key Laboratory of Advanced
hemical Engineering, Nanjing University,
nju.edu.cn
emistry, University of California, Irvine,
iversity of California, Irvine, California,
(ESI) available: Synthetic procedures,
ional details, NMR and mass spectra.
is work.
hemistry 2019further improved by scaﬀold tuning.19 6-Substituted triazines
are also remarkably inert to other biological functionality.
The enhanced stability of the triazine enabled its direct
application in genetic code expansion and recombinant
protein production.18 Additionally, while 6-substituted
triazines react eﬃciently with TCO, they do not react with
other bioorthogonal alkenes, including norbornene and
cyclopropene.18 This result is in sharp contrast to related
tetrazine motifs, which react vigorously with a variety of
alkenes and alkynes.12,13,20–28
To expand upon the unique features of triazines, we aimed to
synthesize and examine the reactivities of alternativelyFig. 1 Inverse electron-demand Diels–Alder (IED-DA) reactions. (A)
Triazine (X ¼ CH) and tetrazine (X ¼ N) scaﬀolds react with strained
alkynes to form stable cycloadducts. (B) Isomeric 1,2,4-triazines and
1,2,4,5-tetrazines examined in this work.
Chem. Sci., 2019, 10, 9109–9114 | 9109
Table 1 DFT-computed activation free energies (kcal mol1) and predicted rate constants (M1 s1) for tetrazine/triazine cycloadditions with
strained dienophiles. Predicted rate constants (in water at 25 C) range from 1010 to 103. Red designates slow (1010 to 104), yellow designates
intermediate (103 to 102), and green designates fast (102 to 103) rates
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View Article Onlinesubstituted rings. 1,2,4-Triazines react with dienophiles to form
new bonds across C3 and C6.18,29 The regioselectivity of this
addition could potentially be exploited for orthogonal reaction
development: 6-substituted triazines would be less likely toTable 2 Second order rate constants (M1 s1) for tetrazine and triazine
at 25 C and monitored via 1H-NMR spectroscopy. Reactions were ru
indicates no reaction after 24 h and a corresponding rate constant (k2) <
a Rate determined in ref. 18. b Reactions were run in 40% CD3OD in CD3
product was observed. d Rate determined in ref. 12. e The rate constant a
9110 | Chem. Sci., 2019, 10, 9109–9114react with bulky dienophiles than their 5-substituted counter-
parts (Fig. 1B). Thus, diﬀerent substitution patterns could
eﬀectively “tune” triazine reactivity and promote selective
cycloaddition. Similar tactics have been used to developcycloadditions with strained dienophiles. All reactions were conducted
n in CD3CN containing 10–50% d-PBS unless otherwise stated. N.R.
104 M1 s1. The color code is deﬁned in Table 1
CN. c Rate not determined. Aer 24 h, 15% conversion to an unisolable
s measured with unsubstituted TCO in ref. 20.
This journal is © The Royal Society of Chemistry 2019
Fig. 2 Isomeric triazines exhibit unique bioorthogonal reactivities. (A) 5-Phenyl-triazine (2) reacts exclusively with TMTH. The reaction was
monitored by 1H-NMR spectroscopy (top). The plot of reaction progress over time is shown below. (B) 5-Phenyl-1,2,4-triazine (2) can be used in
combination with disubstituted tetrazine and cyclopropene scaﬀolds. The reagents were combined and monitored by 1H-NMR spectroscopy
(top). The plot of reaction progress over time is shown below.
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View Article Onlinemutually compatible reactions with tetrazines.10 For example,
mono-substituted tetrazines react rapidly even with sterically
encumbered cyclooctynes.30,31 By contrast, disubstituted tetra-
zines do not react with similar alkynes due to steric clashes in
the transition states.32
To examine whether diﬀerentially substituted triazines could
provide mutually orthogonal reactions, we rst used density
functional theory (DFT) calculations at the M06-2X/6-
311+G(d,p)//M06-2X/6-31G(d) level to evaluate the reactivities of
model probes.33–36 Isomeric triazines and substituted tetrazines
were included in the analyses, along with a panel of bio-
orthogonal strained dienophiles (Table 1).37–41 The triazine
motifs diﬀered in their substitution patterns, with phenyl
groups positioned at C3 and C6 (the sites of new bond forma-
tion in cycloaddition reactions), or C5. In agreement with our
previous work, triazines were predicted to react readily with
TCO, although more slowly than their tetrazine counterparts.
Minimal or no triazine reactivity was predicted with other
strained alkenes, including 1-methylcyclopropene andThis journal is © The Royal Society of Chemistry 2019norbornene. Structurally related tetrazines, by contrast, harbor
much lower LUMO+1 energies and were predicted to react
robustly with a variety of strained alkenes.42
When evaluating strained alkynes, the reactivity proles of
the triazine isomers diverged. The 5-substituted scaﬀold was
predicted to react with tetramethylthiacycloheptyne (TMTH, 9),
a sterically encumbered cycloalkyne developed by the Bertozzi
group.43 The 3- and 6-substituted isomers were predicted to
exhibit diminished reactivity with TMTH due to steric clashes at
the reactive centers. Calculations further suggested that none of
the triazine isomers would react eﬃciently with other strained
alkynes, including DIBO and DIFO (molecules with lower
HOMO energies), setting the stage for orthogonal reaction
development.
To validate the computational predictions, we synthesized
the panel of reagents shown in Table 2. The triazine and tetra-
zine scaﬀolds were incubated with a variety of strained alkenes
and alkynes, and the reactions were monitored by 1H-NMR
spectroscopy (Fig. S1–S10†). The measured bimolecular rateChem. Sci., 2019, 10, 9109–9114 | 9111
Fig. 3 Orthogonal [4 + 2] cycloadditions. All reagents (2.5 mM) were
combined and the reactions were monitored by HPLC (210 nm). Two
distinct cycloadducts were observed.
Fig. 4 Distortion/interaction analysis of factors controlling mutually
orthogonal cycloadditions. Black arrows are activation potential
energies, green and blue arrows are distortion energies of dienophile
and diene, respectively, and red arrows are interactions energies. All
values are given in kcal mol1.
Chemical Science Edge Article
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View Article Onlineconstants closely matched those predicted by DFT calculations
(Table 2). The 6-substituted triazine (1) reacted at a reasonable
rate with TCO, but no other strained alkene (4–6). The 5-phenyl
isomer (2) was also eﬃciently ligated with TCO, but reacted
minimally with cyclopropene 4 (Fig. S3–S5†). Importantly, the
most tantalizing prediction—robust reactivity between TMTH
(9) and 5-phenyl-1,2,4-triazine (2)—was also validated (Fig. S9–
S11†). The reaction proceeded with a rate constant of k2 ¼ 0.22
 0.01 M1 s1. This rate is on par with many commonly used
distortion-accelerated azide–alkyne cycloadditions.2,44–47 Under
similar conditions, no reactivity was observed between 6-
substituted triazine (1) and TMTH (9) (Fig. S12†). Even with
a more reactive triazine (S3), minimal reactivity was observed
(Fig. S13†). The selective reactivity of 2 with TMTH (9) was9112 | Chem. Sci., 2019, 10, 9109–9114further showcased in a competition experiment (Fig. 2). When
the isomeric triazines were combined in equimolar amounts
and treated with excess TMTH (9), only the 5-substituted
triazine (2) was consumed (Fig. 2A).
The unique reactivity prole of 5-phenyl triazine (2) sug-
gested immediate opportunities for mutually orthogonal
reaction development. While triazine 2 reacts quickly with
TMTH (9), this isomer is refractory to ligation with bio-
orthogonal cyclopropenes (scaﬀolds known to react robustly
with tetrazines, Fig. S14 and S15†). Since tetrazines and
cyclopropenes are both inert to TMTH and triazines
(Fig. S16†), these reagents could be exploited for dual [4 + 2]
cycloaddition. To examine this possibility, triazine 2 was rst
mixed with cyclopropene 5 and tetrazine 3. Over the course of
the reaction, the concentration of triazine 2 remained
constant, while cyclopropene 5 and tetrazine 3 were consumed
(Fig. 2B). When all four model reagents were combined
(2.5 mM, 1 equiv.), the two expected cycloadducts were
observed (Fig. 3, S17 and S18†). Similar results were obtained
using a more reactive cyclopropene in the mixture (Fig. S19†).
To our knowledge, these are the rst examples of [4 + 2] IED-
DA cycloadditions that can be used concurrently without
cross-reactivity.3 Bonger and colleagues recently reported
a pair of [4 + 2] cycloadditions for dual labeling, but precise
reagent stoichiometries were required to prevent oﬀ-target
reactions.13
The mutual orthogonality of the reagents from this work
arises from the interplay of intrinsic reactivities and steric
factors.18,48 Tetrazines are more reactive than triazines with
bioorthogonal dienophiles due to the lower LUMO+1 energies
of the p-systems.42,49,50 This intrinsic order of reactivity is
manifested in the “Distortion/Interaction-Activation Strain
Model”51 analysis shown in Fig. 4. The sterically unhindered
cyclopropene reacts most slowly with 2, slightly faster with 1,
and fastest with the tetrazine analog. These diﬀerences in
reactivity arise from increased interaction energies that parallel
the increasing electrophilicity across the series. The same
behavior is observed with other sterically unhindered dien-
ophiles, such as the highly reactive TCO. With a sterically
hindered dienophile (e.g., TMTH), though, the opposite trend is
observed. The more hindered tetrazine reacts most slowly with
TMTH (9), while the less hindered 5-phenyl triazine (2) ligates
most rapidly. TMTH reactivity is mainly controlled by distortion
energies that are strongly inuenced by steric considerations.
Balancing electronic interaction energies (that enhance reac-
tivity) with steric eﬀects (that increase distortion energies and
thus decrease reactivity) is a general approach for developing
mutually orthogonal bioorthogonal reactions.11,36,48
Encouraged by the computational and experimental anal-
yses, we examined whether the orthogonal cycloadditions could
be used in more complex environments. Toward this end, we
attempted the labeling reactions in concert with two model
proteins (GFP and NanoLuciferase, Nluc). We attached a single
5-substituted triazine to Nluc using cysteine-maleimide chem-
istry (Fig. S20 and Scheme S1†). In this case, Nluc was engi-
neered to harbor a single cysteine at residue 180.52 The resulting
conjugate (Nluc-Triazine) was readily ligated with TMTH (9,This journal is © The Royal Society of Chemistry 2019
Fig. 5 Orthogonal [4 + 2] cycloadditions enable dual protein labeling.
(A) Nluc-Triazine and GFP-Cp were mixed 1 : 1 in PBS (pH 7.3, 2 mM),
and subsequently treated with TMTH (9) and tetrazine 3 (1 mM). (B)
Quantitative conversion to the expected cycloadducts was observed
after 3 h via mass spectrometry. N-Terminal methionine cleavage
(–Met) was observed for both proteins and their respective
cycloadducts.
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View Article OnlineFig. S21†). We further prepared a cyclopropene-GFP (GFP-Cp)
conjugate via genetic code expansion (Fig. S21†).53 The model
proteins were combined 1 : 1 in PBS (pH 7.3, 2 mM nal
concentration). Themixture was then treated with TMTH (9) and
tetrazine 3. Aer 3 h, full consumption of the starting proteins
was observed via mass spectrometry (Fig. 5, S21 and S22†). No
cross-reactivities were observed, suggesting that the cycloaddi-
tions can be used to label two biological targets simultaneously.
The orthogonal [4 + 2] cycloadditions could also be performed in
the presence of lysate, conditions that mimic cellular environ-
ments (Fig. S23†). The cycloadditions were also compatible with
polar bioorthogonal reactants, enabling simultaneous, triple-
component ligations (Fig. S24 and S25†). Collections of three
mutually orthogonal reactions are rare.54,55
In conclusion, we identied isomeric triazine scaﬀolds that
exhibit unique cycloaddition proles. Computational and
experimental analyses of triazine reactivity were performed.
Isomeric triazines were found to react robustly with TCO, but
only the least sterically encumbered isomers (5-substituted)
reacted with other dienophiles. Notably, 5-substituted 1,2,4-
triazines reacted eﬃciently with TMTH, one of the most steri-
cally encumbered strained alkynes reported to date. The cyclo-
addition was successfully used in combination with another
popular IED-DA reaction, the tetrazine ligation with 1-methyl-
cyclopropene. These mutually compatible reactions can be used
in tandem to tag protein targets in biologically relevant envi-
ronments. Future work will address the need for functionalThis journal is © The Royal Society of Chemistry 2019TMTH conjugates. TMTH has been historically diﬃcult to outt
with uorophores and other reporter groups, although new
strategies for derivatization are being pursued. A panel of easily
accessible reagents will further enhance multi-component
labeling applications.
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